DAE HWA Pharmaceutical Co. Ltd - Asset Resilience Ratio

Latest as of March 2026: 2.26%

DAE HWA Pharmaceutical Co. Ltd (067080) has an Asset Resilience Ratio of 2.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of DAE HWA Pharmaceutical Co. Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩5.03 Billion

≈ $3.41 Million USD Cash + Short-term Investments

Total Assets

₩222.33 Billion

≈ $150.67 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how DAE HWA Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. See DAE HWA Pharmaceutical Co. Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down DAE HWA Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of DAE HWA Pharmaceutical Co. Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩5.03 Billion	2.26%
Total Liquid Assets	₩5.03 Billion	2.26%

Asset Resilience Insights

Limited Liquidity: DAE HWA Pharmaceutical Co. Ltd maintains only 2.26% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

DAE HWA Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio

Compare DAE HWA Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Bausch Health Companies Inc TO:BHC	Drug Manufacturers - Specialty & Generic	4.97%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Hainan Haiyao Co Ltd SHE:000566	Drug Manufacturers - Specialty & Generic	3.27%
Shanxi Zhendong Pharmaceutical SHE:300158	Drug Manufacturers - Specialty & Generic	10.74%

Annual Asset Resilience Ratio for DAE HWA Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual Asset Resilience Ratio data for DAE HWA Pharmaceutical Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.25%	₩4.75 Billion ≈ $3.22 Million	₩210.86 Billion ≈ $142.90 Million	+0.92pp
2024-12-31	1.33%	₩2.74 Billion ≈ $1.85 Million	₩205.88 Billion ≈ $139.52 Million	-1.32pp
2023-12-31	2.64%	₩5.80 Billion ≈ $3.93 Million	₩219.16 Billion ≈ $148.52 Million	+0.29pp
2022-12-31	2.35%	₩4.68 Billion ≈ $3.17 Million	₩199.06 Billion ≈ $134.90 Million	-4.56pp
2021-12-31	6.91%	₩12.26 Billion ≈ $8.31 Million	₩177.38 Billion ≈ $120.21 Million	+3.29pp
2020-12-31	3.62%	₩6.34 Billion ≈ $4.29 Million	₩175.05 Billion ≈ $118.63 Million	-1.71pp
2019-12-31	5.33%	₩8.86 Billion ≈ $6.01 Million	₩166.15 Billion ≈ $112.59 Million	-4.60pp
2018-12-31	9.94%	₩16.10 Billion ≈ $10.91 Million	₩162.06 Billion ≈ $109.82 Million	+1.20pp
2017-12-31	8.74%	₩14.46 Billion ≈ $9.80 Million	₩165.47 Billion ≈ $112.14 Million	-0.86pp
2016-12-31	9.60%	₩14.76 Billion ≈ $10.00 Million	₩153.80 Billion ≈ $104.23 Million	+7.81pp
2015-12-31	1.79%	₩2.23 Billion ≈ $1.51 Million	₩124.61 Billion ≈ $84.45 Million	-1.38pp
2014-12-31	3.17%	₩3.93 Billion ≈ $2.66 Million	₩124.07 Billion ≈ $84.08 Million	+1.80pp
2013-12-31	1.37%	₩1.67 Billion ≈ $1.13 Million	₩121.87 Billion ≈ $82.59 Million	-1.15pp
2012-12-31	2.52%	₩3.27 Billion ≈ $2.22 Million	₩130.19 Billion ≈ $88.23 Million	-1.88pp
2011-12-31	4.39%	₩5.96 Billion ≈ $4.04 Million	₩135.58 Billion ≈ $91.88 Million	--

pp = percentage points

About DAE HWA Pharmaceutical Co. Ltd

KQ:067080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$121.32 Million

₩179.02 Billion KRW

Market Cap Rank

#18545 Global

#840 in Korea

Share Price

₩10220.00

Change (1 day)

-2.20%

52-Week Range

₩10220.00 - ₩23300.00

All Time High

₩45034.77